Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1992 4
1993 1
1994 1
1995 2
1997 2
1999 2
2001 1
2002 2
2003 4
2004 1
2005 5
2006 7
2007 6
2008 4
2009 7
2010 4
2011 8
2012 7
2013 10
2014 10
2015 12
2016 14
2017 16
2018 14
2019 12
2020 21
2021 17
2022 9
2023 3
2024 11
2025 9
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Results by year

Filters applied: . Clear all
Page 1
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.
Fokas E, Appelt A, Glynne-Jones R, Beets G, Perez R, Garcia-Aguilar J, Rullier E, Smith JJ, Marijnen C, Peters FP, van der Valk M, Beets-Tan R, Myint AS, Gerard JP, Bach SP, Ghadimi M, Hofheinz RD, Bujko K, Gani C, Haustermans K, Minsky BD, Ludmir E, West NP, Gambacorta MA, Valentini V, Buyse M, Renehan AG, Gilbert A, Sebag-Montefiore D, Rödel C. Fokas E, et al. Among authors: sebag montefiore d. Nat Rev Clin Oncol. 2021 Dec;18(12):805-816. doi: 10.1038/s41571-021-00538-5. Epub 2021 Aug 4. Nat Rev Clin Oncol. 2021. PMID: 34349247 Free article. Review.
Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, Sebag-Montefiore D, Tekkis P, Brown G; Magnetic Resonance Imaging in Rectal Cancer European Equivalence Study Study Group. Taylor FG, et al. Among authors: sebag montefiore d. J Clin Oncol. 2014 Jan 1;32(1):34-43. doi: 10.1200/JCO.2012.45.3258. Epub 2013 Nov 25. J Clin Oncol. 2014. PMID: 24276776 Clinical Trial.
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.
Rao S, Sclafani F, Eng C, Adams RA, Guren MG, Sebag-Montefiore D, Benson A, Bryant A, Peckitt C, Segelov E, Roy A, Seymour MT, Welch J, Saunders MP, Muirhead R, O'Dwyer P, Bridgewater J, Bhide S, Glynne-Jones R, Arnold D, Cunningham D. Rao S, et al. Among authors: sebag montefiore d. J Clin Oncol. 2020 Aug 1;38(22):2510-2518. doi: 10.1200/JCO.19.03266. Epub 2020 Jun 12. J Clin Oncol. 2020. PMID: 32530769 Free PMC article. Clinical Trial.
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D. James RD, et al. Among authors: sebag montefiore d. Lancet Oncol. 2013 May;14(6):516-24. doi: 10.1016/S1470-2045(13)70086-X. Epub 2013 Apr 9. Lancet Oncol. 2013. PMID: 23578724 Clinical Trial.
International consensus definition of low anterior resection syndrome.
Keane C, Fearnhead NS, Bordeianou L, Christensen P, Espin Basany E, Laurberg S, Mellgren A, Messick C, Orangio GR, Verjee A, Wing K, Bissett I; LARS International Collaborative Group. Keane C, et al. Colorectal Dis. 2020 Mar;22(3):331-341. doi: 10.1111/codi.14957. Epub 2020 Feb 10. Colorectal Dis. 2020. PMID: 32037685 Free article.
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.
Gilbert A, Adams R, Webster J, Gilbert DC, Abbott NL, Berkman L, Bottomley D, Brown SR, Casanova N, Copeland J, Falk S, Glynne-Jones R, Goh V, Hawkins MA, Khan S, Muirhead R, Rao S, Renehan AG, Richman SD, Ruddock S, Smith A, Stewart AJ, Whibley M, Wood HM, Sebag-Montefiore D, Harrison M; PLATO trial study group. Gilbert A, et al. Among authors: sebag montefiore d. Lancet Oncol. 2025 Jun;26(6):707-718. doi: 10.1016/S1470-2045(25)00213-X. Epub 2025 May 4. Lancet Oncol. 2025. PMID: 40334666 Free article. Clinical Trial.
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.
Samuel R, Knight SR, Adams R, Das P, Dorth J, Finch D, Guren MG, Hawkins MA, Moug S, Rajdev L, Sebag-Montefiore D, Renehan AG, Fish R; plus the CORMAC-2 collaborators. Samuel R, et al. Among authors: sebag montefiore d. EClinicalMedicine. 2024 Dec 5;78:102939. doi: 10.1016/j.eclinm.2024.102939. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39720423 Free PMC article. Review.
Chemoradiation schedules--what radiotherapy?
Glynne-Jones R, Sebag-Montefiore D. Glynne-Jones R, et al. Among authors: sebag montefiore d. Eur J Cancer. 2002 Jan;38(2):258-69. doi: 10.1016/s0959-8049(01)00370-7. Eur J Cancer. 2002. PMID: 11803142 Review.
The Impact of National Radiotherapy Guidelines: The UK Anal Cancer Story.
Adams R, Drinkwater K, Gilbert DC, Hawkins MA, Sebag-Montefiore D, Thorpe N, Muirhead R. Adams R, et al. Among authors: sebag montefiore d. Clin Oncol (R Coll Radiol). 2024 Oct;36(10):593-595. doi: 10.1016/j.clon.2024.06.048. Epub 2024 Jun 20. Clin Oncol (R Coll Radiol). 2024. PMID: 39025732 No abstract available.
Outcome measures in multimodal rectal cancer trials.
Fokas E, Glynne-Jones R, Appelt A, Beets-Tan R, Beets G, Haustermans K, Marijnen C, Minsky BD, Ludmir E, Quirke P, Sebag-Montefiore D, Garcia-Aguilar J, Gambacorta MA, Valentini V, Buyse M, Rödel C. Fokas E, et al. Among authors: sebag montefiore d. Lancet Oncol. 2020 May;21(5):e252-e264. doi: 10.1016/S1470-2045(20)30024-3. Lancet Oncol. 2020. PMID: 32359501 Review.
200 results